Neuromuscular Disorders
Volume 18, Issue 3 , Pages 248-258 , March 2008

Adenovirus and adeno-associated virus-mediated delivery of human myophosphorylase cDNA and LacZ cDNA to muscle in the ovine model of McArdle’s disease: Expression and re-expression of glycogen phosphorylase

  • J.McC. Howell

      Affiliations

    • Department of Veterinary Biology and Biomedical Science, Murdoch University, Perth 6150, WA, Australia
    • Center for Neuromuscular and Neurological Disorders, University of Western Australia, Perth, WA, Australia
    • Corresponding Author InformationCorresponding author. Address: Department of Veterinary Biology and Biomedical Science, Murdoch University, Perth 6150, WA, Australia. Tel.: +61 08 9310 4144; fax. +61 08 9360 6630.
    • ,
  • K.R. Walker

      Affiliations

    • Center for Medical Research, University of Western Australia, Perth, WA, Australia
    • ,
  • L. Davies

      Affiliations

    • Department of Veterinary Biology and Biomedical Science, Murdoch University, Perth 6150, WA, Australia
    • ,
  • E. Dunton

      Affiliations

    • Department of Veterinary Biology and Biomedical Science, Murdoch University, Perth 6150, WA, Australia
    • ,
  • A. Everaardt

      Affiliations

    • Department of Veterinary Biology and Biomedical Science, Murdoch University, Perth 6150, WA, Australia
    • ,
  • N. Laing

      Affiliations

    • Center for Medical Research, University of Western Australia, Perth, WA, Australia
    • ,
  • G. Karpati

      Affiliations

    • Montreal Neurological Institute, McGill University, Montreal, Que., Canada

Received 5 June 2007 ,Revised 11 September 2007 ,Accepted 30 October 2007.

References 

  1. Newgard CB, Littman DR, van Genderen C, Smith M, Fletterick RJ. Human Brain Glycogen Phosphorylase: cloning, sequence analysis, chromosomal mapping, tissue expression, and comparison with the human liver and muscle isozymes. J Biol Chem. 1988;263:3850–3857
  2. McArdle B. Myopathy due to a defect in muscle glycogen breakdown. Clin Sci. 1951;10:13
  3. Pearson C, Rimer D, Mommaerts F. A metabolic myopathy due to absence of muscle phosphorylase. Am J Med. 1961;30:502–517
  4. DiMauro S, Andreau AL, Bruno C, Hadjigeorgiou GM. Myophosphorylase deficiency (glycogenosis type V; McArdle disease). Curr Mol Med. 2002;2:189–196
  5. Milstein J, Herron T, Haas J. Fatal infantile phosphorylase deficiency. J Child Neurol. 1989;4:186
  6. Tan P, Allen J, Wilton S, Akkari P, Huxtable C, Laing N. A splice-site mutation causing ovine McArdle’s disease. Neuromuscul Disord. 1997;7:336–342
  7. Angelos S, Valberg S, Smith B, et al. Myophosphorylase deficiency associated with rhabdomyolysis and exercise intolerance in 6 related Charolais cattle. Muscle Nerve. 1995;18:736–740
  8. Weitzman MD, Thistlethwaite PA. Breaking the barriers to global gene delivery. Nat Biotechnol. 2005;23:305–306
  9. Pari G, Crerar M, Nalbantoglu J, et al. Myophosphorylase gene transfer in McArdle’s disease myoblasts in vitro. Neurology. 1999;53:1152–1154
  10. Howell J JMcC, Lochmuller H, O’Hara AJ, et al. High-level dystrophin expression after adeno-virus mediated dystrophin minigene transfer to skeletal muscle of dystrophic dogs: prolongation of expression with immunosuppression. Hum Gene Ther. 1998;9:629–634
  11. Acsadi G, Jani A, Massie B, et al. A differential efficiency of adenovirus-mediated in vitro gene transfer into skeletal muscle cells of different maturity. Hum Mol Genet. 1994;3:579–584
  12. Xiao X, Li J, Samulski R. Production of high-titre recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol. 1998;72:2224–2232
  13. Takeuchi T, Kuriali H. Histochemical detection of phosphorylase in animal tissues. J Histochem Cytochem. 1955;3:153–160
  14. Sartore S, Gorza L, Schiaffino S. Fetal myosin heavy chains in regenerating muscle. Nature. 1982;298(5871):294–296
  15. Gallanti A, Perelle A, Maggio M, et al. Desmin and vimentin as markers of regeneration in muscle disease. Acta Neuropath (Berl). 1992;85(1):88–89
  16. Minamide LS, Bamburg JR. A filter paper dye-binding assay for quantitative determination of protein without interference from reducing agents or detergents. Anal Biochem. 1990;190:66–70
  17. DiMauro S, Arnold S, Miranda A, Rowland L. McArdle’s disease: the mystery of re-appearing phosphorylase activity in muscle culture – a fetal isoenzyme. Ann Neurol. 1978;3:60–66
  18. O’Hara AJ, Howell JMCC, Taplin RH, et al. The spread of transgene expression at the site of gene construct injection. Muscle Nerve. 2001;24:488–495
  19. Yuasa K, Sakamoto M, Miyagoe-Suzuki Y, et al. Adeno-associated virus vector mediated gene transfer into dystrophin-deficient skeletal muscle evokes enhanced immune response. Gene Ther. 2002;9:1576–1588
  20. Yamamoto K, Yuasa K, Miyagoe Y, et al. Immune response to adenovirus delivered antigens upregulates utrophin and results in mitigation of muscle pathology in mdx mice. Hum Gene Ther. 2000;11:669–680
  21. Waheed I, Gilbert R, Nalbantoglu J, Guibinga GH, Petrof BJ, Karpati G. Factors associated with induced chronic inflammation in mdx skeletal muscle cause posttranslational stabilization and augmentation of extrasynaptic sarcolemmal utrophin. Hum Gene Ther. 2005;489–501
  22. Roelofs R, Engel W, Chauvin P. Histochemical demonstration of phosphorylase activity in regenerating skeletal muscle fibres from myophosphorylase deficient patients. Science. 1972;177:795–797
  23. Martinuzzi A, Schievano G, Nascimbeni A, Fanin M. McArdle’s disease; the unsolved mystery of the reappearing enzyme. Am J Pathol. 1999;154:1893–1897
  24. Cabello A, Benlloch T, Franch O, Feliu JF, Ricoy JR. Glycogen storage disease in skeletal muscle. Morphological, ultrastructural and biochemical aspects in 10 cases. Acta Neuropathol Suppl (Berl). 1981;7:297–300
  25. Mitsumoto H. McArdle disease: phosphorylase activity in regenerating muscle fibres. Neurology. 1979;29:258–262
  26. Grunfeld JP, Ganeval D, Chanard J, Fardeau M, Dreyfus JC. Acute renal failure in McArdle’s disease. Report of two cases. N Engl J Med. 1972;286:1237–1241
  27. Karpati G. Mitigation of deleterious effects of certain abnormal genes in immature skeletal muscle cells. Trends Neurosci. 1984;360–361
  28. Sato K, Imai F, Hatayama I, Roelofs RI. Characterization of glycogen phosphorylase isoenzymes present in cultured skeletal muscle from patients with McArdle’s disease. Biochem Biophys Res Commun. 1977;78:663–668
  29. Nalbantoglu J, Pari G, Karpati G, Holland P. Expression of the primary coxsackie and adenovirus receptor is downregulated during skeletal muscle maturation and limits the efficacy of adenovirus-mediated gene delivery to muscle cells. Hum Gene Ther. 1999;10:1009–1119
  30. Wang Z, Zhu T, Qiao C, et al. Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat Biotechnol. 2005;23:321–328
  31. Nalbantoglu J, Larochelle N, Wolr E, Karpati G, Lochmuller H, Holland P. Muscle-specific overexpression of the adenovirus primary receptor CAR overcomes low efficiency of gene transfer to mature skeletal muscle. J Virol. 2001;75:4276–4282
  32. Gregorevic P, Blankinship MJ, Allen JM, et al. Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat Med. 2004;10:828–834

PII: S0960-8966(07)00760-2

doi: 10.1016/j.nmd.2007.10.006

Neuromuscular Disorders
Volume 18, Issue 3 , Pages 248-258 , March 2008

Article Tools

* Image Usage & Resolution